Tyme stock price3/25/2023 ![]() ![]() Systematic retrieval of data or other content from, whether to create or compile, post to other websites, directly or indirectly, as text, video or audio, a collection, compilation, database or directory, is prohibited absent our express prior written consent. Tyme Technologies, Inc NASDAQ: TYME is a biotechnology company focused on developing cancer metabolism-based therapies for a solid. the closing price of the Common Stock, as published in The Wall Street. Any other use, including for any commercial purposes, is strictly prohibited without our express prior written consent. 2015 Equity Incentive Plan (the Plan) is hereby. You may use and the contents contained in solely for your own individual non-commercial and informational purposes only. Liable for your own investment decisions and agree to the Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology indications. Users should not base their investment decision upon . (TYME): 0.31 0.02 (+8.07) POWR Rating Component Grades Sign Up to See Ratings.FREE We have 9 different ratings for every stock to help you appreciate its future potential. ![]() Get the latest COMPANYNAME TYME detailed stock quotes, stock data, Real-Time ECN, charts. is a research service that provides financial data and technical analysis of publicly traded stocks.Īll users should speak with their financial advisor before buying or selling any securities. Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology. TYME stock price today + long-term Tyme Technologies - TYME stock price, relative strength, and seasonality charts to give you perspective on todays TYME. View COMPANYNAME TYME investment & stock information. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |